JOGO Health, a prescription digital therapeutics company, is transforming care for muscle dysfunction with EMG biofeedback. JOGO device offers precision muscle retraining with measurable outcomes facilitating neuroplasticity. JOGO provides non-surgical & painless solutions for urinary and fecal incontinence, chronic constipation, pelvic organ prolapse, voiding dysfunction, post stroke spasticity etc. Recommended by global guidelines, including the American Urology Association & American Gastroenterological Association, EMG biofeedback is recommended for pelvic floor disorders.

JOGO is 510K exempted and has also received the ‘Breakthrough Device’ status for chronic low back pain by US FDA in 2023. With clinical research partnerships with prestigious institutions, including Mayo Clinic and Harvard Medical School, JOGO has successfully treated over 15,000 patients worldwide.

In India, JOGO collaborates with 50+ leading hospitals across major cities such as Chennai, Bangalore, Mumbai, Kolkata, Delhi.  With operation in the US, Canada, India, Malaysia, and soon in the UAE and Europe, JOGO Health is redefining rehabilitation, empowering patients to reclaim their lives confidently.